MOVE Earnings

MOVE reported its FY2025Q2 earnings on 2025-09-24, showcasing a revenue of 103.00K against an estimate of 3.41M, resulting in a -96.98% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a -6.18% price change on the earnings day and a -4.9% change over the next five days, reflecting market reactions to the results.

Following MOVE's FY2025Q2 earnings announcement on 2025-09-24, the stock price moved by -6.18% on the day of the release. Over the subsequent five days, it saw a -4.9% change. Historically, MOVE's stock price tends to shift by an average of 6.92% in the 10 days leading up to earnings and -2.18% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate MOVE's annual revenue to reach 4.80M, while the EPS is projected at -6.70. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MOVE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MOVE's stock price typically moves by 6.92% in the 10 days before its earnings and -2.18% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -6.70 and revenue of 4.80M.

The earnings call highlights both positive and negative aspects. While there are improvements in operating loss and cash position, the reverse stock split for Nasdaq compliance and competitive pressures are concerning. The Q&A reveals optimism about product development and market opportunities but also shows management's vague responses about critical timelines. The potential partnerships and FDA clearance could be positive catalysts, but the financial strain and competitive landscape balance the sentiment. Given the mixed signals, the stock price is likely to remain neutral in the short term.